The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany

Menopause

Volumn 12, Issue 4, 2005, Pages 405-411

  Heitmann, Cornelia ^a   Greiser, Eberhard ^a   Dören, Martina ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Postmenopausal hormone therapy; Risk communication; Survey; Women's Health Initiative Randomized Controlled Trial

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTHROPATHY; ARTICLE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EDUCATION; FEMALE; GERMANY; HEALTH SURVEY; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYSTERECTOMY; INTERPERSONAL COMMUNICATION; INTERVIEW; MAJOR CLINICAL STUDY; MASS MEDIUM; MEDICAL INFORMATION; MICTURITION DISORDER; MOOD DISORDER; MUSCLE DISEASE; OSTEOPOROSIS; OVARIECTOMY; PHYSICIAN; POSTMENOPAUSE; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; TELEPHONE;

AGE DISTRIBUTION; EDUCATIONAL STATUS; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERVIEWS; MASS MEDIA; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 23244455416     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000153890.77135.00     Document Type: Article

References (25)

1. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
2. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-944.
3. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
4. Beckmann MW, Braendle W, Brucker C, et al. Konsensus-Empfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause. [Consensus recommendations regarding use of postmenopausal hormones in the climacteric period and in the postmenopause.] Frauenarzt 2003;44:138-141. Available at: http://www.dggg.de, including updated version of May 2004. Accessed November 17, 2004.
5. Arzneimittelkommission der deutschen Ärzteschaft. Hormontherapie im Klimakterium, 2003. [Drug Commission of the German Medical Association. Menopausal Hormone use. 2003.] Available at: http://www.akdae.de/35/101lefte/ 82_Hormontherapie_2003_1Auflage.pdf. Accessed November 17, 2004.
6. Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH. Available at: http://www.forsa.de. Accessed November 17, 2004 and May 12, 2005.
7. Robert-Koch-Institut. Bundesgesundheitssurvey 1998. Public use file. [National Health Examination Survey 1998.] Available at: http://www.rki.de/ GESUND/DATEN/BGSURVEY/BGSURVEY.HTM. Accessed November 17, 2004.
8. Löwel H, Heier M, Schneider A, Gösele U, Meisinger C. Hormontherapie. Vergleiche sind zulässig. [Hormone therapy: comparisons are justified.] Deutsches Ärzteblatt 2003;40:2008-2009.
9. Greiser E. Gutachten zur Anwendung der postmenopausalen Hormontherapie in Deutschland und Vorschläge zur Senkung der Anwendungshäufigkeit (2003). [Expert report regarding postmenopausal hormone therapy use in Germany and suggestions to reduce prevalence of use of HT.] Available at: http://www.landtag.nrw.de/WWW/GB_1/1.1/EK/EK2/Greiser%20Enquete-Gutachten%2011. 8.03.pdf. Accessed November 17, 2004.
10. Zawinell A, Dören M. Tritt auf die Verordnungsbremse. (Translation from German: Decrease of hormone therapy prescriptions). Gesundheit Gesellschaft 2003;12:30-33.
11. Ettinger B, Woods NF, Barrett-Connor E, Pressman A. The North American Menopause Society 1998 menopause survey: part II. Counselling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause 2000;7:143-148.
12. Breslau ES, Davis WW, Doner L, et al. The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003;58:33-43.
13. Ettinger B, Grady B, Tosteson ANA, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-1232.
14. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA 2002;288:366-368.
15. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184-188.
16. Buist DSM, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-1050.
17. Bestul MB, McCollum M, Hansen LB, Saseen JJ. Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy 2004;24:495-499.
18. Austin PC, Mamdani MM, Tu K, Jaakkimainen L. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study. JAMA 2003;289:3241-3242.
19. Schwabe U, Rabe T. Sexual hormone. In: Schwabe, Paffrath D, eds. Arzneiverordnungsreport 2003. Berlin, Heidelberg: Springer Verlag, 2003:776-798.
20. Deitermann B. Die Hormontherapie in den Wechseljahren: Hat die neue Erkenntnislage die Verordnungspraxis verändert? [Postmenopausal hormone therapy: did new evidence change prescription patterns?] In: Glaeske G, Janhsen K, eds. GEK-Arzneimittelreport 2004. St. Augustin: Asgard-Verlag, 2004:101-126. Available at: http://media.gek.de/downloads/magazine/ ArzneimittelReport04vorlaeufig_GEK.pdf. Accessed November 17, 2004.
21. Bluemel JE, Castelo-Branco C, Chedraui PA, et al Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004;11:57-61.
22. Ena G, Rozenberg S. Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study. Hum Reprod 2003;18:2245-2248.
23. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197-202.
24. Jantke A, Bühling KJ, Sehouli J, Pfüller B, Hindenburg H-J, Lichtenegger W. Zum Einfluss der WHI-Studie auf die Hormonsubstitution in der Praxis - Ergebnisse einer Umfrage unter Frauenärztinnen/innen in Berlin. [The impact of the WHI study on prescribing attitudes regarding hormone replacement therapy: a survey among gynecologists in Berlin.] Geburtshshilfe Frauenheilkd 2003;63:560-565.
25. Kolip P, Bucksch J, Deitermann B. Websites wider besseres Wissen. Hormontherapie im Internet. [Postmenopausal hormone therapy on the internet- against one's better judgement.] Gesundheit Gesellschaft 2003;12:34-35.